Surmodics Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Surmodics Inc 公司

Surmodics, Inc. 是血管内医疗器械高性能涂层技术以及体外诊断免疫测定测试和微阵列化学和生物组件的供应商。该公司还开发和销售高度差异化的血管介入医疗器械，这些医疗器械旨在满足尚未满足的临床需求，并根据苛刻的要求进行设计。其部门包括医疗器械和 IVD。医疗器械部门制造和授权高性能涂层，包括表面改性涂层技术，以改善医疗器械的可及性、可输送性和可预测性部署，以及药物输送涂层技术，以从医疗器械表面提供特定部位的药物输送，终端市场包括神经血管、外周和冠状动脉。IVD 部门制造用于诊断和生物医学研究市场中的体外诊断免疫测定和分子测试的化学和生物组件。

Surmodics Inc简介



公司代码SRDX

公司名称Surmodics Inc

上市日期Mar 04, 1998

CEOMr. Gary R. Maharaj

员工数量389

证券类型Ordinary Share

年结日Mar 04

公司地址9924 W 74th St

城市EDEN PRAIRIE

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编55344

电话19525007000

网址https://www.surmodics.com/

公司代码SRDX

上市日期Mar 04, 1998

CEOMr. Gary R. Maharaj

Surmodics Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Gary R. Maharaj

President, Chief Executive Officer, Director

192.06K

-2.07%

Mr. Timothy J. Arens

Chief Financial Officer, Senior Vice President - Finance and Information Technology

67.30K

-1.84%

Mr. Joseph J. Stich

Senior Vice President of Human Resources, President - In Vitro Diagnostics

59.53K

-1.71%

Mr. Charles W. Olson

Senior Vice President, President - Medical Device Coatings

52.28K

-1.80%

Dr. David R. Dantzker, M.D.

Independent Director

40.18K

+2.71%

Ms. Susan E. (Sue) Knight

Non-Executive Independent Chairman of the Board

37.24K

+5.95%

Mr. Jose H. Bedoya

Independent Director

30.01K

+3.63%

Mr. Gordon S. Weber, J.D.

Senior Vice President - Legal, General Counsel, Secretary

21.04K

-1.49%

Ms. Lisa Wipperman Heine

Independent Director

13.98K

+3.90%

Ms. Teryl L.W. Sides

Senior Vice President, President - Vascular Interventions

--

名称

名称/职务

职务

持股

持股变动

Mr. Gary R. Maharaj

President, Chief Executive Officer, Director

192.06K

-2.07%

Mr. Timothy J. Arens

Chief Financial Officer, Senior Vice President - Finance and Information Technology

67.30K

-1.84%

Mr. Joseph J. Stich

Senior Vice President of Human Resources, President - In Vitro Diagnostics

59.53K

-1.71%

Mr. Charles W. Olson

Senior Vice President, President - Medical Device Coatings

52.28K

-1.80%

Dr. David R. Dantzker, M.D.

Independent Director

40.18K

+2.71%

Ms. Susan E. (Sue) Knight

Non-Executive Independent Chairman of the Board

37.24K

+5.95%

收入明细

单位: USD更新时间: 10月6日周一

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

暂无数据

地区USD

名称

营收

占比

Domestic

104.64M

83.00%

Foreign

21.43M

17.00%

业务

地区

暂无数据

股东统计

更新时间: 8月16日周六

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

7.13%

AllianceBernstein L.P.

5.95%

The Vanguard Group, Inc.

5.66%

Soleus Capital Management, L.P.

5.52%

Gabelli Funds, LLC

5.22%

其他

70.52%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

7.13%

AllianceBernstein L.P.

5.95%

The Vanguard Group, Inc.

5.66%

Soleus Capital Management, L.P.

5.52%

Gabelli Funds, LLC

5.22%

其他

70.52%

股东类型

持股股东

占比

Investment Advisor/Hedge Fund

39.31%

Investment Advisor

24.73%

Hedge Fund

22.33%

Research Firm

4.06%

Individual Investor

3.88%

Bank and Trust

0.51%

Sovereign Wealth Fund

0.22%

Pension Fund

0.09%

Insurance Company

0.03%

其他

4.84%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

312

12.95M

90.59%

-4.14M

2025Q2

321

12.64M

88.41%

-4.03M

2025Q1

343

12.58M

88.00%

-4.09M

2024Q4

362

12.66M

88.58%

-3.97M

2024Q3

348

12.66M

88.74%

-3.48M

2024Q2

329

13.91M

98.26%

-1.49M

2024Q1

308

13.31M

93.49%

-1.66M

2023Q4

311

13.68M

96.13%

-630.83K

2023Q3

314

12.98M

91.82%

-1.55M

2023Q2

312

12.97M

91.74%

-1.29M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

1.02M

7.13%

-27.06K

-2.58%

Jun 30, 2025

AllianceBernstein L.P.

850.47K

5.95%

+1.12K

+0.13%

Jun 30, 2025

The Vanguard Group, Inc.

810.18K

5.67%

+11.51K

+1.44%

Jun 30, 2025

Soleus Capital Management, L.P.

789.06K

5.52%

--

Jun 30, 2025

Gabelli Funds, LLC

745.83K

5.22%

+26.83K

+3.73%

Jun 30, 2025

Trium Capital LLP

716.78K

5.01%

+716.78K

--

Jul 11, 2025

UBS Financial Services, Inc.

422.72K

2.96%

+356.98K

+543.00%

Jun 30, 2025

Hudson Bay Capital Management LP

400.00K

2.8%

-64.97K

-13.97%

Jun 30, 2025

Qube Research & Technologies Ltd

393.98K

2.76%

+4.80K

+1.23%

Jun 30, 2025

Readystate Asset Management LP

433.61K

3.03%

+433.61K

--

Jun 30, 2025

持股ETF



更新时间: 11月6日周四

机构名称

占比

First Trust Merger Arbitrage ETF

4.36%

SPDR S&P Health Care Equipment ETF

0.45%

Inspire Small/Mid Cap ESG ETF

0.19%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.08%

iShares Micro-Cap ETF

0.08%

iShares U.S. Medical Devices ETF

0.05%

Franklin US Small Cap Multifactor Index ETF

0.05%

iShares Russell 2000 Growth ETF

0.03%

ProShares Hedge Replication ETF

0.02%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

0.02%

First Trust Merger Arbitrage ETF

占比4.36%

SPDR S&P Health Care Equipment ETF

占比0.45%

Inspire Small/Mid Cap ESG ETF

占比0.19%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

占比0.08%

iShares Micro-Cap ETF

占比0.08%

iShares U.S. Medical Devices ETF

占比0.05%

Franklin US Small Cap Multifactor Index ETF

占比0.05%

iShares Russell 2000 Growth ETF

占比0.03%

ProShares Hedge Replication ETF

占比0.02%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

占比0.02%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据